Skip to main content
Premium Trial:

Request an Annual Quote

A Night to Get Out the Vogt

Last night, some 150 cancer researchers and people devoted to the field gathered at the Hilton New York to honor Peter Vogt of The Scripps Research Institute, winner of the 2010 Szent-Györgyi Prize for Progress in Cancer Research. The award was sponsored by the National Foundation for Cancer Research, which was cofounded by Albert Szent-Györgyi in 1973.

John Lechleiter, CEO of Eli Lilly and Company, gave a keynote speech at the award dinner. In it, he said that two main drivers in defeating cancer would be tailored therapies and increased collaboration among pharmas, academia, and more. Establishing those partnerships will necessitate figuring out what information is truly competitive and what can be shared, he said. "The next generation of cancer treatments must be more tailored," he added.

In accepting his award, Vogt's comments reminded attendees of why he's renowned both as a cancer researcher and as a principal investigator. Included in his list of people to thank were the people who have gone through his lab: "The character and quality of a lab are determined by its postdocs and grad students," he said. Vogt's work began with studies of Rous sarcoma virus, but he is best known for his research around P1 3-kinase and elucidating the protein-protein interaction of Myc and Max. Read more about the award in the official announcement.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.